Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
about
CAR-T cell therapy in ovarian cancer: from the bench to the bedside.Large scale ex vivo expansion of clinical-grade effector cells for adoptive immunotherapy.Toll-like receptor 2 costimulation potentiates the antitumor efficacy of CAR T Cells.New Chimeric Antigen Receptor Design for Solid Tumors.The Potential of CAR T Cell Therapy in Pancreatic Cancer
P2860
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
@en
type
label
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
@en
prefLabel
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
@en
P2093
P2860
P1476
Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors.
@en
P2093
Bing-Lan Zhang
Di-Yuan Qin
Yong-Sheng Wang
Yu-Quan Wei
Ze-Ming Mo
P2860
P2888
P304
P356
10.1007/S11427-016-5027-4
P577
2016-03-11T00:00:00Z
P5875
P6179
1011504316